| scholarly article | Q13442814 |
| P50 | author | Jacqueline M. Katz | Q87082629 |
| Suryaprakash Sambhara | Q104742683 | ||
| Weiping Cao | Q114722210 | ||
| Jin Hyang Kim | Q114722211 | ||
| Victoria Jeisy-Scott | Q114722215 | ||
| P2093 | author name string | William G Davis | |
| P2860 | cites work | Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis | Q21256673 |
| Making better influenza virus vaccines? | Q22305647 | ||
| Recognition of single-stranded RNA viruses by Toll-like receptor 7 | Q24568101 | ||
| TLR signaling pathways | Q24570127 | ||
| The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults | Q24622008 | ||
| A Critical Role for Induced IgM in the Protection against West Nile Virus Infection | Q27485124 | ||
| TLR signaling | Q28291637 | ||
| Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function | Q29617462 | ||
| In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses | Q29619174 | ||
| Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function | Q30233581 | ||
| The origin and virulence of the 1918 "Spanish" influenza virus. | Q30361962 | ||
| Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. | Q30365337 | ||
| Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. | Q30371866 | ||
| In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. | Q30373090 | ||
| Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. | Q30383200 | ||
| New strategies to overcome the drawbacks of currently available flu vaccines. | Q30384057 | ||
| Phylogenetic analysis of surface proteins of novel H1N1 virus isolated from 2009 pandemic | Q30386247 | ||
| Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 | ||
| The first influenza pandemic of the new millennium | Q30401658 | ||
| Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells | Q31032363 | ||
| Comparison of human B cell activation by TLR7 and TLR9 agonists | Q33354786 | ||
| Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice | Q34038100 | ||
| Toll-like receptor 7 controls the anti-retroviral germinal center response | Q34048099 | ||
| MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection | Q34416382 | ||
| Inflammasomes as mediators of immunity against influenza virus | Q34474244 | ||
| Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. | Q34875973 | ||
| Endocytosis of influenza viruses | Q35862726 | ||
| Differential roles for RIG-I-like receptors and nucleic acid-sensing TLR pathways in controlling a chronic viral infection. | Q35903286 | ||
| Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells | Q36178686 | ||
| B cell intrinsic TLR signals amplify but are not required for humoral immunity | Q36294387 | ||
| Influenza and the challenge for immunology | Q36452600 | ||
| Toll-like receptors and innate immunity in B-cell activation and antibody responses | Q36791457 | ||
| Inflammasome recognition of influenza virus is essential for adaptive immune responses | Q37061831 | ||
| Toll-like receptors--sentries in the B-cell response | Q37672658 | ||
| Different B cell populations mediate early and late memory during an endogenous immune response | Q37712769 | ||
| Improving immunogenicity and effectiveness of influenza vaccine in older adults | Q37951523 | ||
| MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination | Q38725392 | ||
| Influenza: propagation, quantification, and storage | Q39943485 | ||
| Toward self-adjuvanting subunit vaccines: model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines | Q42021841 | ||
| Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response | Q42227086 | ||
| Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion | Q44831120 | ||
| Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes | Q45184856 | ||
| Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination | Q45400025 | ||
| Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways | Q45537161 | ||
| Role of IgM antibodies versus B cells in influenza virus-specific immunity | Q45731092 | ||
| Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production | Q46154630 | ||
| Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production | Q46257088 | ||
| TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses | Q47892185 | ||
| Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. | Q51027487 | ||
| Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. | Q51991421 | ||
| Toll-like receptor stimulation as a third signal required for activation of human naive B cells. | Q53632191 | ||
| Live attenuated versus inactivated influenza vaccine in infants and young children. | Q55043222 | ||
| Control of B-cell responses by Toll-like receptors | Q59066168 | ||
| Control of early viral and bacterial distribution and disease by natural antibodies | Q73257312 | ||
| Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes | Q73295212 | ||
| Low CD3+CD28-induced interleukin-2 production correlates with decreased reactive oxygen intermediate formation in neonatal T cells | Q77312734 | ||
| TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses | Q79717981 | ||
| Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses | Q79818181 | ||
| Oil-in-water emulsion adjuvant with influenza vaccine in young children | Q85087747 | ||
| P433 | issue | 20 | |
| P921 | main subject | pandemic | Q12184 |
| antibody | Q79460 | ||
| toll-like receptor | Q408004 | ||
| P304 | page(s) | 10988-10998 | |
| P577 | publication date | 2012-07-25 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice | |
| P478 | volume | 86 |
| Q37409898 | A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways |
| Q30367140 | Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. |
| Q34262084 | Acute clearance of human metapneumovirus occurs independently of natural killer cells |
| Q59350551 | Biological sex affects vaccine efficacy and protection against influenza in mice |
| Q90412990 | Cytokine production in whole-blood cultures following immunization with an influenza vaccine |
| Q36481466 | Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice |
| Q42202779 | Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines |
| Q41912227 | H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production |
| Q36522870 | Host genetics of severe influenza: from mouse Mx1 to human IRF7 |
| Q58100162 | How the Respiratory Epithelium Senses and Reacts to Influenza Virus |
| Q30354091 | Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. |
| Q52649839 | Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus. |
| Q42273669 | Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis |
| Q38737075 | Influenza infection in human host: challenges in making a better influenza vaccine |
| Q58583857 | Innate Immunity Induces the Accumulation of Lung Mast Cells During Influenza Infection |
| Q30365302 | Innate immune sensing and response to influenza. |
| Q33923354 | Innate immunity to influenza virus infection |
| Q28082761 | Paradoxical changes in innate immunity in aging: recent progress and new directions |
| Q35197357 | Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults |
| Q42051356 | Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice. |
| Q98946621 | Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans |
| Q30366722 | Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins. |
| Q50335684 | Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation via Toll-Like Receptor 7. |
| Q37254256 | TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate |
| Q34313957 | The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors |
| Q37192137 | The battle between influenza and the innate immune response in the human respiratory tract |
| Q49343115 | The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells |
| Q64068650 | The dual role of innate immunity during influenza |
| Q57824353 | The role of respiratory epithelium in host defence against influenza virus infection |
| Q37712843 | Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice. |
Search more.